Home » SPIRE RECEIVES FDA CLEARANCE TO MARKET COATED LONG-TERM DIALYSIS CATHETER
SPIRE RECEIVES FDA CLEARANCE TO MARKET COATED LONG-TERM DIALYSIS CATHETER
May 26, 2006
Spire Corporation announced May 25 that it has received clearance from the U.S. Food and Drug Administration (FDA) to market a coated hemodialysis catheter. The coating on this next generation catheter is firmly bonded to both internal and external catheter surfaces, and has demonstrated the ability to reduce thrombus and fibrin sheath formation in both in vitro and animal studies.
Spire (http://phx.corporate-ir.net/phoenix.zhtml?c=76421&p=irol-newsArticle&ID=860900&highlight=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct